PubMed

Long-term dual blockade with candesartan and lisinopril in hypertensive patients with diabetes: the CALM II study.

Andersen NH, Poulsen PL, Knudsen ST, Poulsen SH, Eiskjaer H, Hansen KW, Helleberg K, Mogensen CE.

Diabetes Care. 2005 Feb;28(2):273-7.PMID: 15677778 [PubMed - indexed for MEDLINE]Related articlesFree article

Pulse pressure lowering effect of dual blockade with candesartan and lisinopril vs. high-dose ACE inhibition in hypertensive type 2 diabetic subjects: a CALM II study post-hoc analysis.

Knudsen ST, Andersen NH, Poulsen SH, Eiskjaer H, Hansen KW, Helleberg K, Poulsen PL, Mogensen CE.

Am J Hypertens. 2008 Feb;21(2):172-6. Epub 2008 Jan 10.PMID: 18188164 [PubMed - indexed for MEDLINE]Related articles

Antihypertensive efficacy of candesartan-lisinopril in combination vs. up-titration of lisinopril: the AMAZE trials.

Izzo JL Jr, Weinberg MS, Hainer JW, Kerkering J, Tou CK; AMAZE.

J Clin Hypertens (Greenwich). 2004 Sep;6(9):485-93.PMID: 15365275 [PubMed - indexed for MEDLINE]Related articles

Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study.

Mogensen CE, Neldam S, Tikkanen I, Oren S, Viskoper R, Watts RW, Cooper ME.

BMJ. 2000 Dec 9;321(7274):1440-4.PMID: 11110735 [PubMed - indexed for MEDLINE]Related articlesFree article

Comparison of the AT1-receptor blocker, candesartan cilexetil, and the ACE inhibitor, lisinopril, in fixed combination with low dose hydrochlorothiazide in hypertensive patients.

McInnes GT, O'Kane KP, Istad H, Keinänen-Kiukaanniemi S, Van Mierlo HF.

J Hum Hypertens. 2000 Apr;14(4):263-9.PMID: 10805052 [PubMed - indexed for MEDLINE]Related articles

Renoprotective effects of adding angiotensin II receptor blocker to maximal recommended doses of ACE inhibitor in diabetic nephropathy: a randomized double-blind crossover trial.

Rossing K, Jacobsen P, Pietraszek L, Parving HH.

Diabetes Care. 2003 Aug;26(8):2268-74.PMID: 12882847 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of dual blockade of the renin-angiotensin system in primary proteinuric nephropathies.

Luño J, Barrio V, Goicoechea MA, González C, de Vinuesa SG, Gómez F, Bernis C, Espinosa M, Ahijado F, Gómez J, Escalada P.

Kidney Int Suppl. 2002 Dec;(82):S47-52.PMID: 12410855 [PubMed - indexed for MEDLINE]Related articles

The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial.

Lithell H, Hansson L, Skoog I, Elmfeldt D, Hofman A, Olofsson B, Trenkwalder P, Zanchetti A; SCOPE Study Group.

J Hypertens. 2003 May;21(5):875-86.PMID: 12714861 [PubMed - indexed for MEDLINE]Related articles

Dual blockade with candesartan cilexetil and lisinopril in hypertensive patients with diabetes mellitus: rationale and design.

Andersen NH, Knudsen ST, Poulsen PL, Poulsen SH, Helleberg K, Eiskjaer H, Hansen KW, Bek T, Mogensen CE.

J Renin Angiotensin Aldosterone Syst. 2003 Jun;4(2):96-9. Review.PMID: 12806591 [PubMed - indexed for MEDLINE]Related articles

Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.

Poldermans D, Glazes R, Kargiannis S, Wernsing M, Kaczor J, Chiang YT, Yen J, Gamboa R, Fomina I.

Clin Ther. 2007 Feb;29(2):279-89.PMID: 17472820 [PubMed - indexed for MEDLINE]Related articles

[Investigations of the antihypertensive long-term action of candesartan cilexetil in different dosages under the influence of therapy-free intervals]

Weisser B, Gerwe M, Braun M, Funken C.

Arzneimittelforschung. 2005;55(9):505-13. German. PMID: 16229114 [PubMed - indexed for MEDLINE]Related articles

Aggressive antihypertensive therapy based on hydrochlorothiazide, candesartan or lisinopril as initial choice in hypertensive type II diabetic individuals: effects on albumin excretion, endothelial function and inflammation in a double-blind, randomized clinical trial.

Schram MT, van Ittersum FJ, Spoelstra-de Man A, van Dijk RA, Schalkwijk CG, Ijzerman RG, Twisk JW, Stehouwer CD.

J Hum Hypertens. 2005 Jun;19(6):429-37.PMID: 15647778 [PubMed - indexed for MEDLINE]Related articles

The effect duration of candesartan cilexetil once daily, in comparison with enalapril once daily, in patients with mild to moderate hypertension.

Himmelmann A, Keinänen-Kiukaanniemi S, Wester A, Redón J, Asmar R, Hedner T; Effect Study Group.

Blood Press. 2001;10(1):43-51.PMID: 11332334 [PubMed - indexed for MEDLINE]Related articles

[Clinical study of the month. The CALM study assessing the combination of an angiotensin-converting enzyme inhibitor and an angiotensin II receptor antagonist in the treatment of diabetic nephropathy]

Philips JC, Weekers L, Scheen AJ.

Rev Med Liege. 2001 Feb;56(2):126-8. French. PMID: 11294048 [PubMed - indexed for MEDLINE]Related articles

Effect of candesartan and lisinopril alone and in combination on blood pressure and microalbuminuria.

Morgan T, Anderson A, Bertram D, MacInnis RJ.

J Renin Angiotensin Aldosterone Syst. 2004 Jun;5(2):64-71.PMID: 15295717 [PubMed - indexed for MEDLINE]Related articles

Optimal dose of candesartan for renoprotection in type 2 diabetic patients with nephropathy: a double-blind randomized cross-over study.

Rossing K, Christensen PK, Hansen BV, Carstensen B, Parving HH.

Diabetes Care. 2003 Jan;26(1):150-5.PMID: 12502672 [PubMed - indexed for MEDLINE]Related articlesFree article

Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.

Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D.

Clin Ther. 2005 May;27(5):578-87.PMID: 15978306 [PubMed - indexed for MEDLINE]Related articles

A twelve-week, multicenter, randomized, double-blind, parallel-group, noninferiority trial of the antihypertensive efficacy and tolerability of imidapril and candesartan in adult patients with mild to moderate essential hypertension: the Iberian Multicenter Imidapril Study on Hypertension (IMISH).

Palma Gámiz JL, Pêgo M, Contreras EM, Anglada MP, Martínez JO, Esquerra EA, Sagastagoitia Gorostiza JD; Iberian Multicenter Imidapril Study on Hypertension.

Clin Ther. 2006 Dec;28(12):2040-51.PMID: 17296460 [PubMed - indexed for MEDLINE]Related articles

Aggressive antihypertensive strategies based on hydrochlorothiazide, candesartan or lisinopril decrease left ventricular mass and improve arterial compliance in patients with type II diabetes mellitus and hypertension.

Spoelstra-de Man AM, van Ittersum FJ, Schram MT, Kamp O, van Dijk RA, Ijzerman RG, Twisk JW, Brouwer CB, Stehouwer CD.

J Hum Hypertens. 2006 Aug;20(8):599-611. Epub 2006 May 4.PMID: 16673014 [PubMed - indexed for MEDLINE]Related articles

The Study on COgnition and Prognosis in the Elderly (SCOPE); outcomes in patients not receiving add-on therapy after randomization.

Lithell H, Hansson L, Skoog I, Elmfeldt D, Hofman A, Olofsson B, Trenkwalder P, Zanchetti A; SCOPE Study Group.

J Hypertens. 2004 Aug;22(8):1605-12.PMID: 15257185 [PubMed - indexed for MEDLINE]Related articles